These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 1360234

  • 1. A chimeric EGFR/neu receptor in studies of neu function.
    Lehtola L, Lehväslaiho H, Koskinen P, Alitalo K.
    Cancer Treat Res; 1992; 61():213-28. PubMed ID: 1360234
    [No Abstract] [Full Text] [Related]

  • 2. A chimeric EGF-R-neu proto-oncogene allows EGF to regulate neu tyrosine kinase and cell transformation.
    Lehväslaiho H, Lehtola L, Sistonen L, Alitalo K.
    EMBO J; 1989 Jan; 8(1):159-66. PubMed ID: 2565807
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms involving an expanding erbB/EGF receptor family of tyrosine kinases in human neoplasia.
    Di Fiore PP, Kraus MH.
    Cancer Treat Res; 1992 Jan; 61():139-60. PubMed ID: 1360229
    [No Abstract] [Full Text] [Related]

  • 4. A chimeric EGFR/neu receptor in functional analysis of the neu oncoprotein.
    Lehtola L, Lehväslaiho H, Koskinen P, Alitalo K.
    Acta Oncol; 1992 Jan; 31(2):147-50. PubMed ID: 1352454
    [Abstract] [Full Text] [Related]

  • 5. The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand.
    Lonardo F, Di Marco E, King CR, Pierce JH, Segatto O, Aaronson SA, Di Fiore PP.
    New Biol; 1990 Nov; 2(11):992-1003. PubMed ID: 1983208
    [Abstract] [Full Text] [Related]

  • 6. HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor.
    Lee J, Dull TJ, Lax I, Schlessinger J, Ullrich A.
    EMBO J; 1989 Jan; 8(1):167-73. PubMed ID: 2565808
    [Abstract] [Full Text] [Related]

  • 7. Deletion-mutant epidermal growth factor receptor in human gliomas: effects of type II mutation on receptor function.
    Humphrey PA, Gangarosa LM, Wong AJ, Archer GE, Lund-Johansen M, Bjerkvig R, Laerum OD, Friedman HS, Bigner DD.
    Biochem Biophys Res Commun; 1991 Aug 15; 178(3):1413-20. PubMed ID: 1678600
    [Abstract] [Full Text] [Related]

  • 8. Role of protein-tyrosine kinases in cellular transformation.
    Varticovski L.
    Sangre (Barc); 1991 Aug 15; 36(4):305-9. PubMed ID: 1663662
    [No Abstract] [Full Text] [Related]

  • 9. A single amino acid substitution is sufficient to modify the mitogenic properties of the epidermal growth factor receptor to resemble that of gp185erbB-2.
    Di Fiore PP, Helin K, Kraus MH, Pierce JH, Artrip J, Segatto O, Bottaro DP.
    EMBO J; 1992 Nov 15; 11(11):3927-33. PubMed ID: 1356764
    [Abstract] [Full Text] [Related]

  • 10. The role of the neu oncogene product in cell transformation and normal development.
    Kokai Y, Wada T, Myers JN, Brown VI, Dobashi K, Cohen J, Hamuro J, Weiner DB, Greene MI.
    Princess Takamatsu Symp; 1988 Nov 15; 19():45-57. PubMed ID: 2908355
    [Abstract] [Full Text] [Related]

  • 11. Activation of the neu tyrosine kinase induces the fos/jun transcription factor complex, the glucose transporter and ornithine decarboxylase.
    Sistonen L, Hölttä E, Lehväslaiho H, Lehtola L, Alitalo K.
    J Cell Biol; 1989 Nov 15; 109(5):1911-9. PubMed ID: 2572601
    [Abstract] [Full Text] [Related]

  • 12. p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.
    Stern DF, Heffernan PA, Weinberg RA.
    Mol Cell Biol; 1986 May 15; 6(5):1729-40. PubMed ID: 2878363
    [Abstract] [Full Text] [Related]

  • 13. Similar early gene responses to ligand-activated EGFR and neu tyrosine kinases in NIH3T3 cells.
    Koskinen P, Lehväslaiho H, MacDonald-Bravo H, Alitalo K, Bravo R.
    Oncogene; 1990 Apr 15; 5(4):615-8. PubMed ID: 1970155
    [Abstract] [Full Text] [Related]

  • 14. Epidermal growth factor receptor, but not c-erbB-2, activation prevents lactogenic hormone induction of the beta-casein gene in mouse mammary epithelial cells.
    Hynes NE, Taverna D, Harwerth IM, Ciardiello F, Salomon DS, Yamamoto T, Groner B.
    Mol Cell Biol; 1990 Aug 15; 10(8):4027-34. PubMed ID: 2196443
    [Abstract] [Full Text] [Related]

  • 15. An oncogenic point mutation confers high affinity ligand binding to the neu receptor. Implications for the generation of site heterogeneity.
    Ben-Levy R, Peles E, Goldman-Michael R, Yarden Y.
    J Biol Chem; 1992 Aug 25; 267(24):17304-13. PubMed ID: 1355090
    [Abstract] [Full Text] [Related]

  • 16. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
    Lehtola L, Sistonen L, Koskinen P, Lehväslaiho H, Di Renzo MF, Comoglio PM, Alitalo K.
    J Cell Biochem; 1991 Jan 25; 45(1):69-81. PubMed ID: 1706346
    [Abstract] [Full Text] [Related]

  • 17. The epidermal growth factor receptor and the product of the neu protooncogene are members of a receptor tyrosine phosphorylation cascade.
    Connelly PA, Stern DF.
    Proc Natl Acad Sci U S A; 1990 Aug 25; 87(16):6054-7. PubMed ID: 1974718
    [Abstract] [Full Text] [Related]

  • 18. Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-alpha genes on in vitro transformation of human mammary epithelial cells.
    Ciardiello F, Gottardis M, Basolo F, Pepe S, Normanno N, Dickson RB, Bianco AR, Salomon DS.
    Mol Carcinog; 1992 Aug 25; 6(1):43-52. PubMed ID: 1354442
    [Abstract] [Full Text] [Related]

  • 19. The role of non-ras transforming genes in chemical carcinogenesis.
    Cooper CS.
    Environ Health Perspect; 1991 Jun 25; 93():33-40. PubMed ID: 1685444
    [Abstract] [Full Text] [Related]

  • 20. Phosphorylation of Hrs downstream of the epidermal growth factor receptor.
    Bache KG, Raiborg C, Mehlum A, Madshus IH, Stenmark H.
    Eur J Biochem; 2002 Aug 25; 269(16):3881-7. PubMed ID: 12180964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.